Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Services

Similar documents
STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.

STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

SAFE HANDLING OF PRESCRIPTION FORMS FOR DOCTORS AND DENTISTS

SAFE HANDLING OF PRESCRIPTION FORMS FOR PRIMARY AND UNPLANNED CARE DIVISIONS

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS

Destruction of Controlled Drugs and Unknown Substances by Pharmacy Services Staff

Guidance For Hospital Pharmacy Staff In NHS Grampian On The Safe Destruction Of Controlled Drugs

CONTROLLED DRUG STANDARD OPERATING PROCEDURE

Medical Needs Policy. Policy Date: March 2017

PROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN

PROCEDURE FOR TAKING A WOUND SWAB

CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS

PROCEDURE FOR IMMUNISATION

PROTOCOL FOR UNIVERSAL ANTENATAL CONTACT (FOR USE BY HEALTH VISITING TEAMS)

CLINICAL PROCEDURE PROCEDURE FOR AN EXPECTED DEATH OF AN ADULT PATIENT FOR COMMUNITY NURSING

Medicines Optimisation Strategy

Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities. July 2011

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.

CONTROLLED DRUG GUIDE FOR CARE HOMES

Good Practice Guidance : Safe management of controlled drugs in Care Homes

CLINICAL PROCEDURE CONSERVATIVE SHARP DEBRIDEMENT FOR COMMUNITY PODIATRISTS

Health & Safety Policy. Author:

Document Title: File Notes. Document Number: 024

NON-MEDICAL PRESCRIBING POLICY

Safe and Secure Handling of MEDICINES POLICY

Policy for Handling the Spillage of Cytotoxic and Anti-Cancer Drugs

JOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.

Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013

Document Title: Investigator Site File. Document Number: 019

MANAGEMENT AND ADMINISTRATION OF MEDICATION. 1. The Scope and Role of the Senior Registered Nurse (SRN)

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Community Infection Prevention and Control Guidance for Health and Social Care. Waste Management

CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES

Standard Operating Procedure

Document Title: Recruiting Process. Document Number: 011

Controlled Drugs Standard Operating Procedure (With the exception of St John s Hospice and DCIS Community Services)

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage

Managing medicines in care homes

Hepatitis B Immunisation procedure SOP

Access to Health Records Procedure

Document Title: Training Records. Document Number: SOP 004

Document Title: Version Control of Study Documents. Document Number: 023

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Safety Reporting in Clinical Research Policy Final Version 4.0

Document Title: GCP Training for Research Staff. Document Number: SOP 005

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case

Sharps Policy Safe Use and Disposal

Version: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018

Clinical and Offensive Waste

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST. Parenteral Concentrated Potassium and Sodium Policy

Unless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version

Administration of urinary catheter maintenance solution by a carer

Adults and Safeguarding Committee 7 th March 2016

Policy Document Control Page

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.

GCP Training for Research Staff. Document Number: 005

Responsible pharmacist requirements: What activities can be undertaken?

POLICY FOR TAKING BLOOD CULTURES

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

MEDICATION POLICY FOR DOMICILIARY CARE IN CEREDIGION

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

Consultant to Consultant Referral Policy

It is essential that patients are aware of, and in agreement with, their referral to palliative care.

MM12: Procedure for Ordering, Receipt, Storage and Monitoring of Medicines in the Community Teams

Contents. About the Pharmacists Defence Association. representing your interests

Purpose This procedure provides guidance on the use and documentation of Controlled Medications

Procedure for Pharmacy Checking of Controlled Drug Stocks Held on Wards & Departments version 5

Document Title: Document Number:

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

Document Title: Research Database Application (ReDA) Document Number: 043

PACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

ADULT SEPSIS SCREEN & BUNDLE (INCLUDING NEUTROPENIC GUIDELINES) FOR ESSENTIAL FIRST HOUR MANAGEMENT GUIDE

COMPETENCIES FOR HEALTHCARE ASSISTANT IN SEXUAL HEALTH (BAND 3)

PROCEDURE FOR CONSERVATIVE DEBRIDEMENT

Drainage of Abdominal Ascites

Policy on Governance Arrangements Relating to Medicines V2.0

Agenda item 3.3 Appendix 4 MANDATORY TRAINING POLICY

Standard Precautions for Infection Control

Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business

Document Title: Research Database Application (ReDA) Document Number: 043

Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service

Protocol for the Emergency Palliative Care Box

Moving and Handling Policy

The Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

PROCEDURE FOR RECORD KEEPING FOR HEALTH VISITING

NHS Grampian Policy and Procedure For The Safe Management Of Controlled Drugs In Hospitals

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Healthcare Support Workers. Administration of Medicines For Specified Children with Complex Needs in the Community

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

TRUST BOARD TB(16) 44. Summary of Lord Carter recommendations Operational productivity and performance in English acute hospitals

Specialised Services: CPL-008 Referral Management Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact

First Aid Policy. Date of Policy November 2016 Date agreed by Governing Body November 2016 Date of next review November 2019

Transcription:

STANDARD OPERATING PROCEDURE Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To ensure stocks of controlled drugs (CDs) in Trust are destroyed in the presence of an authorised witness in a safe and appropriate manner within current legislative requirements 2014 Named Responsible Officer:- Approved by Date Medicines Governance Pharmacist Accountable Officer for Controlled Drugs Section:- Medicines Management MMSOP: 27 Quality, Patient Experience, and Risk Group June 2012 Target Audience Witnesses authorised by the Controlled Drugs Accountable Officer to witness destruction of Controlled drugs and Clinical Leads and Senior Practitioners who are employed by services that stock Controlled Drugs UNLESS THIS VERSION HAS BEEN TAKEN DIRECTLY FROM TRUST WEB SITE THERE IS NO ASSURANCE THIS IS THE CORRECT VERSION

CONTROL RECORD Title Standard Operating Procedure for Witnessing the Destruction of Stock Controlled Drugs Purpose To ensure stocks of controlled drugs (CDs) in Wirral Community Trust are destroyed in the presence of an authorised witness in a safe and appropriate manner within current legislative requirements Author Quality and Governance Service (QGS) and L Knight Impact Assessment Incorporated into procedure Yes No Subject Experts Medicines Governance Pharmacist Document Librarian QGS Groups consulted with :- N/A Infection Control Approved N/A Date formally approved by 7 th June 2012 Quality, Patient Experience, and Risk Group Method of distribution Email Intranet Archived Date Location:- S Drive QGS Access Via QGS VERSION CONTROL RECORD Version Number Author Status Changes / Comments Version 1 L Knight New Status New / Revised / Trust Change 2/7

NAME OF DIS CIPLINE : TRUST WIDE OBJECTIVES To ensure stocks of controlled drugs (CDs) in Wirral Community Trust are destroyed in the presence of an authorised witness in a safe and appropriate manner within current legislative requirements SCOPE To cover all aspects of the destruction of stock controlled drugs from Wirral Community Trust This standard operating procedure does not cover the destruction of patient s own controlled drugs. See separate SOP for Destruction of Patients Controlled Drugs in the Community TARGET GROUP (Staff authorised to follow this SOP) This standard operating procedure (SOP) applies only to witnesses authorised by Wirral Community NHS Trust s Controlled Drugs Accountable Officer to witness the destruction of stock controlled drugs within the Trust and to Heads of and Senior Practitioners who are employed by Trust that have Controlled Drugs as stock EVIDENCE TO SUPPORT Amendment to Misuse of Drugs Regulations 2001 August 2007 Guidance for Pharmacists on the Safe Destruction of Controlled Drugs England, Scotland and Wales Royal Pharmaceutical Society September 2007 A Guide to Good Practice in the Management of Controlled Drugs in Primary Care (England) National Prescribing Centre Third Edition December 2009 Trust Policy GP11 Safe Handling and Administration of Medicines IT IS T HE R E S PONS IB ITITY OF ALL STAFF TO COMPLY WITH RELEVANT T R US T P OL IC IE S, PROCEDURES AND PROTOCOLS IN CONJUNCTION WITH THIS PROCEDURE PROCEDURE ACTIVITY RATIONALE RESPONSIBILITY 1. Trust Service to make an appointment with an authorised witness When stock controlled drugs (CDs) that are out of date or not required are identified, the Clinical Lead is responsible for making an appointment with an to supervise the destruction of the CDs (Contact the Quality and Governance Service on Telephone 0151 514 2202 or internally on 6015) A senior practitioner employed by the service will be present throughout the process and they are responsible for the physical destruction of To comply with Misuse of Drugs Regulations 2001 the drugs and for making the necessary entries 3/7 Clinical Lead in conjunction with a senior practitioner

in the register. Controlled Drugs Destruction Kits must be provided by the service themselves. Controlled drug destruction kits (DOOP kits) can be ordered from NHS Supply Chain code for 250ml kit is KYA003 2. Ensure selection of appropriate authorised witness Quality and Governance Team members that are authorised to witness the destruction of CDs are directly accountable to the Accountable Officer (AO) and must individually read and sign this SOP before undertaking this role. To comply with Misuse of Drugs Regulations 2001 The must ensure that they do not have day to day responsibility for the handling of Controlled Drugs within their job role. Refer to individual authorisation for full details 3. Destruction of Controlled Drugs Destruction of CDs should take place in a room with a sink and at a time when no patients, or members of the public need to use the room The CDs to be destroyed should have been appropriately recorded, marked and segregated (within the CD Cupboard) prior to the visit. The AO should be informed of any concerns. The senior practitioner must be requested to complete a list of the items to be destroyed The CDs segregated for destruction should be removed from the CD cupboard and reconciled with the CD Register The senior practitioner must destroy the CDs using the Controlled Drugs Destruction Kit, by following the instructions on the kit. All stages of this process must be in the presence of the It is advisable for the senior practitioner destroying the CDs to wear a facemask and gloves if available To ensure no distraction and to maintain security To ensure there are no discrepancies To ensure appropriate destruction For protection against particles Senior Practitioner and Authorised Witness 4/7

1. Shake container to loosen granules 2. Add CDs to container, ensuring no more than half full/or to the manufacturer s fill mark 3. Crush tablets before adding (the addition of a small amount of water will minimise any dust) 4. Add powders and liquids directly into kit (adding the liquids last) 5. Break open ampoules before adding, putting both the contents and the glass into the kit 6. For patches remove backing, fold over and place in kit 7. Fill to capacity with water 8. Replace lid securely 9. Shake thoroughly 10. Contents will congeal in 3 to 5 minutes 11. Sealed container to be placed in the CD cupboard whilst the inactivation process is taking place of CD dust The CDs are now considered irretrievable and the responsibility of the authorised witness is complete After 24 hours the kit should be added to a standard clinical waste sharps bin/pharmaceutical waste bin for disposal by secure incineration 4. Records When stock CDs are destroyed the following details must be entered into the register on the relevant pages: The drug name, form and strength The quantity of drug being destroyed The date of destruction The signature of the Senior Practitioner employed by the service The signature of authorised witness together with printed name, and full job title stating their authority to witness, e.g. authorised by AO The must make a Trust record of the controlled drugs destroyed. The Quality and Governance Controlled Drug Stock Destruction Record Book, held in the Quality and Governance Office should To comply with legislation This is considered good practice Senior Practitioner in conjunction with the 5/7

be taken on the visit and the full details of destructions should be recorded. If the record book is not available, the record should be made on the same day or next working day. 5. Discrepancies If any discrepancies are noted in the Controlled Drug Register, the authorised witness should make a detailed note of the discrepancy and report to the AO within 1 working day and complete an incident report. The presence of a discrepancy does not necessarily prevent the destruction taking place. The should consider the risks (if any) of not destroying the CDs during the visit, recording what has, or has not, been destroyed and include any relevant information 6. Clinical Incidents Any related incidents arising from carrying out this procedure which may involve a clinical error or near miss must be reported following the Trust s Incident Reporting Policy. To prevent the unnecessary destruction of evidence To maintain patient safety and comply with Trust Incident Reporting system for effective clinical governance Health professional or delegated staff member EQUALITY ASSESSMENT During the development of this procedure the Trust has considered the clinical needs of each protected characteristic (age, disability, gender, gender reassignment, pregnancy and maternity, race, religion or belief, sexual orientation). There is no clinical evidence of exclusion of these named groups. If staff become aware of any clinical exclusions that impact on the delivery of care, this must be documented using the Trust s incident reporting system and an appropriate action plan put in place TR AINING SPECIALIST COMPETENCIES OR QUAL IF IC AT IONS C ONT INUING E DUC AT ION & T R AINING As per Trust s Training Matrix for each service Training if necessitated by changes in legislation 1. Staff must comply with the Trust s Training Matrix which specifies mandatory training requirements. 2.In addition staff must comply with their service level training matrix for training and competencies as required for role 6/7

3. All staff to have an annual appraisal ORGANISATION DEPARTMENT (IF APPLICABLE) Wirral Community NHS Trust Quality and Governance Service STANDARD OPERATING PROCEDURE APPROVED BY: Peer Review Forum Trust Formal Approval Medicines Management Group Quality, Patient Experience and Risk Group 7/7